Skip to main content

Want a detailed portfolio tracker?

Q32 Bio (QTTB) P/E (2018 - 2026)

Q32 Bio (QTTB) P/E from Mar 28, 2018 to Jul 20, 2026. The TTM Q32 Bio (QTTB) P/E is -5.37. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Q32 Bio (QTTB)

YearP/EChange
2026-5.37+456.95%
2025-0.96+10.39%
2024-0.87+51.70%
2023-0.58-96.52%
2022-16.55+662.61%
2021-2.17-46.61%
2020-4.06-52.01%
2019-8.47-46.00%
2018-15.69N/A

Comparison Q32 Bio (QTTB) P/E with competitors

Q32 Bio (QTTB) P/E is -5.37.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.39%
FGENFibroGen Inc0.24-104.47%
CHRSCoherus Biosciences Inc0.85-115.81%
FBIOFortress Biotech Inc0.95-117.69%
ORMPOramed Pharmaceuticals Inc1.50-128.01%
AGENAgenus Inc3.01-156.09%
INVAInnoviva Inc3.15-158.78%
VXRTVaxart Inc3.55-166.16%
CRMDCorMedix Inc3.63-167.62%
CVACCureVac N.V.4.45-182.85%
GLPGGalapagos NV4.86-190.55%
SRPTSarepta Therapeutics Inc4.88-190.99%
ABEOAbeona Therapeutics Inc5.39-200.41%
ABUSArbutus Biopharma Corp5.60-204.28%
ZVRAZevra Therapeutics Inc5.89-209.72%
SPROSpero Therapeutics Inc6.23-216.08%
CGENCompugen Ltd6.31-217.67%
RIGLRigel Pharmaceuticals6.87-228.07%
SLXNSilexion Therapeutics Corp7.30-235.98%
OMEROmeros Corporation9.26-272.55%
AUPHAurinia Pharmaceuticals Inc9.58-278.63%
PLXProtalix BioTherapeutics Inc10.89-302.97%
ACADAcadia Pharmaceuticals Inc11.73-318.58%
TBPHTheravance Biopharma Inc12.26-328.53%
ADMAAdma Biologics Inc12.42-331.43%
HRMYHarmony Biosciences Holdings Inc13.82-357.56%
SABSSAB Biotherapeutics Inc14.14-363.45%
NAGENiagen Bioscience Inc14.82-376.16%
INCYIncyte Corp15.82-394.88%
REGNRegeneron Pharmaceuticals Inc15.86-395.52%
PBYIPuma Biotechnology Inc17.32-422.71%
CPRXCatalyst Pharmaceuticals Inc17.44-425.01%
EXELExelixis Inc17.54-426.85%
TGTXTG Therapeutics Inc18.97-453.47%
MDXGMimedx Group Inc20.55-483.03%
XOMAXOMA Royalty Corp22.87-526.32%
ARGXArgen X SE24.30-552.85%
CTMXCytomX Therapeutics Inc24.82-562.60%
XOMAOXOMA Royalty Corp25.34-572.36%
HALOHalozyme Therapeutics Inc25.62-577.56%
XOMAPXOMA Royalty Corp25.67-578.42%
VRTXVertex Pharmaceuticals Inc27.99-621.75%
RPRXRoyalty Pharma plc - Class A28.69-634.66%
SLNOSoleno Therapeutics Inc29.02-640.77%
ASNDAscendis Pharma A/S30.09-660.71%
LGNDLigand Pharmaceuticals Inc - Class B37.91-806.58%
APLSApellis Pharmaceuticals Inc39.02-827.25%
BMRNBiomarin Pharmaceutical Inc42.21-886.72%
KRYSKrystal Biotech Inc45.34-945.08%
ONCBeiGene Ltd69.54-1396.05%
PHARPharming Group N.V.75.03-1498.28%
TECHBio-Techne Corp101.96-2000.23%
VCELVericel Corp109.92-2148.64%
ALNYAlnylam Pharmaceuticals Inc117.96-2298.56%
GMABGenmab140.29-2714.65%
TLXTelix Pharmaceuticals Ltd162.15-3122.10%
CORTCorcept Therapeutics Inc212.86-4067.10%